Skip to main content
Equibles

STOREBRAND ASSET MANAGEMENT AS

Position in NBIX — Neurocrine Biosciences Inc

CIK 1685676 LYSAKER, Q8
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,191,746
+$1,115,206 QoQ
Shares Held
7,071
+1117.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#378
of 773 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STOREBRAND ASSET MANAGEMENT AS holds $68,472,125 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 91,690 $49,680,392
2 VTRS
Viatris Inc
 685,858 $10,891,425
3 ZTS
Zoetis Inc.
 93,356 $6,708,562
4 NBIX
Neurocrine Biosciences Inc
This page 		7,071 $1,191,746

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,191,746 7,071
2026-03-31 $76,540 581
2025-12-31 $622,066 4,386
2025-09-30 $615,706 4,386
2025-06-30 $523,121 4,162
2025-03-31 $562,401 5,085
2024-12-31 $4,816,675 35,287
2024-09-30 $11,182,331 97,052
2024-06-30 $10,803,928 78,477
2024-03-31 $10,515,986 76,247
2023-12-31 $10,163,307 77,135
2023-09-30 $12,023,212 106,873
2023-06-30 $10,139,701 107,526
2023-03-31 $13,463,575 133,013
2022-12-31 $12,192,076 102,077
2022-09-30 $721,272 6,791
2022-06-30 $661,986 6,791
2022-03-31 $636,656 6,791
2021-12-31 $619,441 7,273
2021-09-30 $697,553 7,273
2021-06-30 $1,095,141 11,253
2021-03-31 $1,094,354 11,253
2020-12-31 $2,612,200 27,253
2020-09-30 $3,035,194 31,564
2020-06-30 $1,288,808 10,564
2020-03-31 $417,430 4,823

Report a Problem

Category
Description
Email (optional, for follow-up)